According to the WHO, stroke is a clinical syndrome caused by vascular lesion. It is characterized by rapidly occurring clinical symptoms and/or signs of focal or generalized cerebral dysfunction lasting more than 24 h or resulting in death [1]. Despite improvements in the treatment of acute stroke, strokes continue to represent the third-leading cause of death in many countries. Therefore, identification and prevention of stroke risk factors are gaining increasing importance. Approximately 70% of stroke risk is attributed to known etiological risk factors, and genetic factors may account for a significant proportion among the remaining unidentified causes [2]. Polymorphisms affecting various genes, such as angiotensin converting enzyme (ACE), thrombinactivatable fibrinolysis inhibitor (TAFI), and nitric oxide synthase (NOS) genes, as suggested by recent advances in genetic research techniques are associated with the incidence of ischemic stroke (3-9). Nitric oxide (NO), an enzyme that regulates the endothelial microenvironment by reducing intracellular calcium levels, inhibits platelet aggregation and vascular smooth muscle cell proliferation, and reduces leukocyte adhesion [4,10]. The enzyme NOS catalyzes a reaction whereby L-arginine is synthesized from the N-terminus of guanidine. There are two forms of NOS: constitutive and inducible. Different genes synthesize different forms of NOS [NOS1 (neuronal NOS), NOS2, and NOS3 (endothelial NOS)] enzymes [11]. The NOS also inhibits the oxidation of low-density lipoprotein, thereby regulating the endothelial microenvironment [4,10]. Thus, any genetic problem disrupting the amount and structure of NO will cause an inclination towards clotting. In some populations, although a significant relationship was found between the risk of ischemic stroke Background/aim: We aimed to investigate the associations between endothelial nitric oxide synthase (eNOS) gene polymorphisms [G894T (rs1799983)], intron 4 (27-bpTR) variable number tandem repeat (VNTR) and T786C (rs2070744), and ischemic stroke in the Anatolian population. Materials and methods: This case-control study included 112 patients with "stroke of undetermined etiology" and 160 controls. Realtime polymerase chain reaction (RT-PCR) analysis was used to analyze these polymorphisms. Between-group frequencies of alleles and genotypes were compared using binary logistic regression analysis. Results: No significant difference was observed between the two groups in terms of the genotype and allele distributions of the eNOS G894T (rs1799983) polymorphism (P > 0.05). The a alleles and the 4b/a and 4a/a genotypes of the intron 4 (27-bpTR) VNTR polymorphism had significantly higher frequencies in the patient group than in the control group (OR: 2.715, P < 0.001; OR: 3.396, P < 0.001; OR: 10.631, P = 0.016, respectively). On the contrary, the TC genotype and C alleles of the T786C (rs2070744) polymorphism had a significantly lower frequency in the patient group than in the control group (OR: 0.244, P < 0.001, OR: 0.605, P = 0.006,...